Literature DB >> 18951076

Primary essential cutis verticis gyrata--a case report.

Henrique N Radwanski1, Marcelo Wilson Rocha Almeida, Ivo Pitanguy.   

Abstract

Cutis verticis gyrata (CVG) is a skin deformity characterised by excessive growth of the skin of the scalp, resulting in furrows and folds which are similar to gyri of the brain cortex. CVG can be classified into two forms: 'primary' (essential and non-essential) and 'secondary'. The primary non-essential type is associated with the neurological and ophthalmological changes, while the primary essential form does not present any other disorder except for the cutaneous alterations. Secondary forms of CVG are much more frequent and accompany other pathologies. The treatment consists of local hygiene and surgical resection of skin excess. This study reports a case of CVG of the primary essential type in a male patient, who was referred to us for a surgical treatment. (c) 2009 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2008        PMID: 18951076     DOI: 10.1016/j.bjps.2008.06.062

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  4 in total

Review 1.  [Primitive essential Cutis verticis gyrata, a rare skin disease: case report and review of literature].

Authors:  Boukind Samira; Dlimi Meriem; Elatiqi Oumkeltoum; Elamrani Driss; Benchamkha Yassine; Ettalbi Saloua
Journal:  Pan Afr Med J       Date:  2014-12-03

2.  Idiopathic Cutis Verticis Gyrata in a Female.

Authors:  Mohamed Amine Ennouhi; Alae Guerrouani; Abdennacer Moussaoui
Journal:  Cureus       Date:  2018-01-23

3.  A Rare Case of Cutis Verticis Gyrata with Underlying Cerebriform Intradermal Nevus.

Authors:  Lisa F Fronek; Kate Braunlich; Maheera Farsi; Richard A Miller
Journal:  Cureus       Date:  2019-12-29

4.  Scalp expansion for giant cutis verticis gyrata secondary to cerebriform intradermal nevus.

Authors:  Wenfang Dong; Huan Wang; Fei Fan
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.